Immunochemical termination of self-tolerance

被引:58
作者
Gruenewald, Jan [1 ]
Tsao, Meng-Lin [1 ]
Perera, Roshan [1 ]
Dong, Liqun [4 ]
Niessen, Frank [2 ]
Wen, Ben G. [4 ]
Kubitz, Diane M. [2 ]
Smider, Vaughn V. [3 ]
Ruf, Wolfram [2 ]
Nasoff, Marc [4 ]
Lerner, Richard A. [1 ]
Schultz, Peter G. [1 ,4 ]
机构
[1] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[4] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA
基金
美国国家卫生研究院;
关键词
TNF-alpha; unnatural amino acids; vaccination; immunogenicity;
D O I
10.1073/pnas.0804157105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ability to selectively induce a strong immune response against self-proteins, or increase the immunogenicity of specific epitopes in foreign antigens, would have a significant impact on the production of vaccines for cancer, protein-misfolding diseases, and infectious diseases. Here, we show that site-specific incorporation of an immunogenic unnatural amino acid into a protein of interest produces high-titer antibodies that cross-react with WT protein. Specifically, mutation of a single tyrosine residue (Tyr(86)) of murine tumor necrosis factor-alpha (mTNF-alpha) to p-nitrophenylaianine (pNO(2)Phe) induced a high-titer antibody response in mice, whereas no significant antibody response was observed for a Tyr(86) -> Phe mutant. The antibodies generated against the pNO(2)Phe are highly cross-reactive with native mTNF-alpha and protect mice against lipopolysaccharide (LPS)-induced death. This approach may provide a general method for inducing an antibody response to specific epitopes of self- and foreign antigens that lead to a neutralizing immune response.
引用
收藏
页码:11276 / 11280
页数:5
相关论文
共 31 条
[1]  
AGGARWAL BB, 1992, TUMOR NECROSIS FACTOR : STRUCTURE-FUNCTION RELATIONSHIP AND CLINICAL APPLICATION, P191
[2]   The structure of mouse tumour-necrosis factor at 1.4 Å resolution:: towards modulation of its selectivity and trimerization [J].
Baeyens, KJ ;
De Bondt, HL ;
Raeymaekers, A ;
Fiers, W ;
De Ranter, CJ .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1999, 55 :772-778
[3]  
Baldridge J, 2006, INFEC DIS, P235
[4]   An expanded eukaryotic genetic code [J].
Chin, JW ;
Cropp, TA ;
Anderson, JC ;
Mukherji, M ;
Zhang, ZW ;
Schultz, PG .
SCIENCE, 2003, 301 (5635) :964-967
[5]   Therapeutic antibodies elicited by immunization against TNF-α [J].
Dalum, I ;
Butler, DM ;
Jensen, MR ;
Hindersson, P ;
Steinaa, L ;
Waterston, AM ;
Grell, SN ;
Feldmann, M ;
Elsner, HI ;
Mouritsen, S .
NATURE BIOTECHNOLOGY, 1999, 17 (07) :666-669
[6]   The K/BxN mouse: a model of human inflammatory arthritis [J].
Ditzel, HJ .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (01) :40-45
[7]  
Keinan E., 2005, CATALYTIC ANTIBODIES
[8]   Rapid development of affinity matured monoclonal antibodies using RIMMS [J].
Kilpatrick, KE ;
Wring, SA ;
Walker, DH ;
Macklin, MD ;
Payne, JA ;
Su, JL ;
Champion, BR ;
Caterson, B ;
McIntyre, GD .
HYBRIDOMA, 1997, 16 (04) :381-389
[9]   CONSTRUCTION AND INITIAL CHARACTERIZATION OF A MOUSE-HUMAN CHIMERIC ANTI-TNF ANTIBODY [J].
KNIGHT, DM ;
TRINH, H ;
LE, JM ;
SIEGEL, S ;
SHEALY, D ;
MCDONOUGH, M ;
SCALLON, B ;
MOORE, MA ;
VILCEK, J ;
DADDONA, P ;
GHRAYEB, J .
MOLECULAR IMMUNOLOGY, 1993, 30 (16) :1443-1453
[10]   TNFα kinoid vaccination-induced neutralizing antibodies to TNFα protect mice from autologous TNFα-driven chronic and acute inflammation [J].
Le Buanec, Helene ;
Delavallee, Laure ;
Bessis, Natacha ;
Paturance, Sebastien ;
Bizzini, Bernard ;
Gallo, Robert ;
Zagury, Daniel ;
Boissier, Marie-Christophe .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (51) :19442-19447